- Home
- OPAD vs BEAT Comparison
OPAD vs BEAT Comparison
Compare OPAD & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPAD | BEAT |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5M | 23.9M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OPAD | BEAT |
|---|---|---|
| Price | $2.46 | $0.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $12.25 | $3.50 |
| AVG Volume (30 Days) | 31.4K | ★ 15.9M |
| Earning Date | 11-02-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.92 | 15.07 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $567,812,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $56.52 | $1,197.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.54 | $0.36 |
| 52 Week High | $6.09 | $4.00 |
Technical Indicators
Market Signals| Indicator | OPAD | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 16.66 | 43.27 |
| Support Level | $0.63 | $0.37 |
| Resistance Level | $2.67 | $0.52 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 1.89 | 4.66 |
Price Performance
Historical ComparisonAbout OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services, including mortgage, listing, renovation, and buyer representation services.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.